iMOVE: Virtual Reality PT Versus Traditional PT
iMOVE
Immersive Virtual Reality for Enhancement of Physical Activity in Pediatric Oncology : a Randomised Control Study (iMOVE)
1 other identifier
interventional
40
1 country
1
Brief Summary
This pragmatic, crossover, randomized controlled study evaluates the efficacy of virtual reality assisted physical therapy (VRPT) for improving the physical activity of hospitalized children as compared to traditional physical therapy. This is a pilot study that will be used to identify patient populations that can benefit the most from VRPT and estimate this effect for future studies. Patients with a significant neurological condition, major developmental disability, active infection of the face or hand, history of severe motion sickness, history of seizures caused by flashing light or had a major surgery within the last 48 hours will be excluded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
May 25, 2023
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
November 18, 2025
November 1, 2025
12 months
May 16, 2023
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ActiGraph data points
Compare the total Metabolic Equivalent of Task (METs) rate of pediatric oncology patients when undergo virtual reality assisted physical therapy and traditional physical therapy measured by ActiGraph watch
During physical therapy session
Secondary Outcomes (8)
Total exercise time spend in moderate-vigorous activity
During physical therapy session
Total exercise time spend in sedentary activity
During physical therapy session
Total exercise time spend in light activity
During physical therapy session
Change in OMNI RPE survey scores
immediately after the physical therapy session
Feasibility and Usability Survey (Parent)
immediately after the physical therapy session
- +3 more secondary outcomes
Study Arms (2)
VRPT then Traditional PT
EXPERIMENTALParticipants will receive Virtual Reality assisted Physical Therapy sessions (VRPT) in the first Physical Therapy (PT) session and will receive traditional Physical Therapy sessions (standard care) in the second Physical Therapy session under the supervision of the accredited physical therapist.
Traditional PT then VRPT
EXPERIMENTALParticipants will receive traditional Physical Therapy (PT) sessions (standard care) in the first Physical Therapy session and Virtual Reality assisted Physical Therapy sessions (VRPT) in the second Physical Therapy session under the supervision of the accredited physical therapist.
Interventions
Participants are allowed to freely choose one game from the game list. Participant will be asked to wear a validated activity tracker - ActiGraph. Baseline heart rate will be collected for 1 minute. Participants will be wearing the ActiGraph during Physical Therapy session. Participants receiving VR intervention will be instructed to wear an Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in VR applications under the supervision of the physical therapist.
Participants will receive traditional Physical Therapy sessions (standard care) under the supervision of the accredited physical therapist. Participants will be wearing the Actigraph during Physical Therapy session. Participants will perform regular physical exercise, such as 20 minutes walking or biking on a stationary bike, under the supervision of a physical therapist.
Eligibility Criteria
You may qualify if:
- Between age 10-25 years
- Diagnosed with cancer
- Has an active physical therapy consultation
- Anticipated inpatient stay for at least 3-days with the second PT session following between 24-72 hours after the first PT session
- Ability to understand and the willingness to personally sign the written Institutional Review Board (IRB) approved informed consent document by Legally Authorized Representative (LAR) if participant \<18 years old or by participant if 18+
- Ability to understand and the willingness to personally sign the written IRB approved informed assent document for patient \<18 years old.
You may not qualify if:
- Legal guardian does not present to obtain consent.
- Child with a significant neurological condition, or major developmental disability.
- Child with active infection of the face or hand.
- A history of severe motion sickness.
- A history of seizures caused by flashing light.
- Major surgery within the last 48 hours.
- Does not speak English (required for surveys)
- With visual impairments or any degree of developmental delays
- Child on mechanical ventilation or ventilatory support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lucile Packard Childrens Hospital Stanford
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Caruso
Stanford University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2023
First Posted
May 25, 2023
Study Start
June 1, 2025
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
November 18, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share